GTBP - What's Going On With GT Biopharma Stock? | Benzinga
GT Biopharma, Inc. (NASDAQ:GTBP) shares are racing higher Monday on heavy trading volume. Here's a look at what's going on.
What To Know:
GT Biopharma shares are moving on heavy trading volume despite a lack of company-specific news. The stock is one of the top trending tickers on Stocktwits which may point to a rally led by retail traders.
According to data from Benzinga Pro, more than 60.4 million shares have been traded in the session, far exceeding the stock’s 100-day average of less than 11,000 shares.
GT Biopharma is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on its TriKE NK cell engager platform. GT Biopharma has an exclusive worldwide license agreement with the University ...